These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38575970)

  • 1. Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada.
    Cunningham NE; Lamb J; Staller A; Krajden M; Hogg RS; Towle A; Lima VD; Salters K
    Harm Reduct J; 2024 Apr; 21(1):75. PubMed ID: 38575970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Equity Health; 2021 Mar; 20(1):81. PubMed ID: 33740984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
    Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
    EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment.
    Talal AH; George SJ; Talal LA; Dharia A; Ventuneac A; Baciewicz G; Perumalswami PV; Dickerson SS
    Res Involv Engagem; 2023 Aug; 9(1):63. PubMed ID: 37533127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
    Goodyear T; Ti L; Carrieri P; Small W; Knight R
    Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities.
    Pearce ME; Jongbloed K; Demerais L; MacDonald H; Christian WM; Sharma R; Pick N; Yoshida EM; Spittal PM; Klein MB
    Int J Drug Policy; 2019 Dec; 74():52-61. PubMed ID: 31525640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.
    Socías ME; Shannon K; Montaner JS; Guillemi S; Dobrer S; Nguyen P; Goldenberg S; Deering K
    Can J Gastroenterol Hepatol; 2015; 29(8):411-6. PubMed ID: 26492129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Sobriety equals getting rid of hepatitis C": A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults.
    Vega TA; Levander XA; Seaman A; Korthuis PT; Englander H
    J Subst Abuse Treat; 2021 Aug; 127():108337. PubMed ID: 34134860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Not just one box that you tick off' - Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective.
    Marshall AD; Rance J; Grebely J; Treloar C
    Int J Drug Policy; 2022 Apr; 102():103610. PubMed ID: 35151085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitated telemedicine for hepatitis C virus: Addressing challenges for improving health and life for people with opioid use disorder.
    Talal AH; Jaanimägi U; Dharia A; Dickerson SS
    Health Expect; 2023 Dec; 26(6):2594-2607. PubMed ID: 37641398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.
    Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM
    Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting.
    Bardwell G; Mansoor M; Van Zwietering A; Cleveland E; Snell D; Kerr T
    Harm Reduct J; 2022 Dec; 19(1):136. PubMed ID: 36476225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study.
    Pearce ME; Bartlett SR; Yu A; Lamb J; Reitz C; Wong S; Alvarez M; Binka M; Velásquez Garcia H; Jeong D; Clementi E; Adu P; Samji H; Wong J; Buxton J; Yoshida E; Elwood C; Sauve L; Pick N; Krajden M; Janjua NZ
    BMC Womens Health; 2021 Sep; 21(1):330. PubMed ID: 34511082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.